AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

Business Wire (July 10, 2007)

Permanent Link: http://vlex.com/vid/avant-deficiency-relating-minimum-bid-55947110
Id. vLex: VLEX-55947110

Acceda a este documento
y pruebe vLex GRATIS durante 3 días

Headnotes:

Business
Business, general
Biological products industry
Securities industry
Stock prices
Financial markets

Extract:

AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

NEEDHAM, Mass. -- AVANT Immunotherapeutics (Nasdaq: AVAN) announced today that on July 6, 2007 it received a letter from The NASDAQ Stock Market stating that for the last 30 consecutive business days, the closing bid price per share for AVANT's common stock has b...

Try vLex for FREE for 3 days

Access legal information from United States including:

Constitutions
Forms and Contracts
Legal Books and Journals
Case Law
News and Business
Regulations
U.S. Code

Try vLex without any commitment for 3 days and see why you need it.

days of Free Access

If you are already a vLex customer, Access Here

Sponsored Ads:

Other documents:

Monroe Knocks Off Top Seed Valley View ; Hornets Build 27-7 Lead, Hold... | RESOLUCION de 12 de enero de 1998 de la Delegación Territorial Servicio Territorial de Industria Com... | Pollution Oceangoing ships and vessels in domestic service, | agency information collection activities submission for omb review... | Entscheidungstext 11Os29/63 Oberster Gerichtshof March 25 1963 | Sentenza nº 261 of T.A.R - Abruzzo Pescara of February 07 2003 | 9 januari 1995 - koninklijk besluit tot wijziging van het koninklijk besluit ... | Decisao Monocratica N 70028844306 of Tribunal de Justica do RS Nona Camara Civel of May ... | Acórdão Nº 81126 of Primeira Turma, of March 08, 2002 | ciclismo

AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

Sponsored Ads:

Headnotes:

Extract:

Sponsored Ads:

News and Business